http://www.freshpatents.com/Chemistry--natural-resins-or-derivatives--peptides-or-proteins--lignins-or-reaction-products-thereof-dtnewntc530.php USPTO Class 530 - Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof en-us Mon, 6 Feb 2012 13:34:01 -0800 1000 Wednesday Thursday Friday Saturday Sunday 141 31 http://www.freshpatents.com/index.php?rss=true http://www.freshpatents.com/images/freshpatentsnav_rss.gif http://www.freshpatents.com/-dt20120202ptan20120029166.php Mon, 6 Feb 2012 13:34:01 -0800 A method of modulation of synthesis capacity on and cleavage properties of synthetic oligomers from solid support is described. The method utilizes linker molecules attached to a solid surface and co-coupling agents that have similar reactivities to the coupling compounds with the surface functional groups. The preferred linker molecules provide... http://www.freshpatents.com/-dt20120202ptan20120029165.php Mon, 6 Feb 2012 13:34:01 -0800 The present invention concerns methods of isolating milk proteins. Methods of the invention include charged ultrafiltration processes that use variations in pH to further separate protein species.... http://www.freshpatents.com/-dt20120202ptan20120029167.php Mon, 6 Feb 2012 13:34:01 -0800 A drug using the magnetic properties of a metal salen complex as represented by the following general formula in order to magnetize the intended drug by chemically binding the drug to a metal salen complex so that the drug can be delivered to the target diseased site. The drug can... http://www.freshpatents.com/-dt20120202ptan20120029168.php Mon, 6 Feb 2012 13:34:01 -0800 The present invention provides a method for ameliorating inflammatory and/or neuropathic pain in a subject by modifying the activity of N-methyl-D-aspartate (NMDA) receptors in cells of the subject by inhibition of the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex.... http://www.freshpatents.com/-dt20120202ptan20120029169.php Mon, 6 Feb 2012 13:34:01 -0800 Tau protein has a causative role in Alzheimer's disease and multiple other neurodegenerative disorders exhibiting tau histopathology collectively termed tauopathies. The primary function of tau protein is to facilitate assembly and maintenance of microtubules in neuronal axons. In the disease process tau protein becomes modified, loses its affinity to microtubules... http://www.freshpatents.com/-dt20120202ptan20120029170.php Mon, 6 Feb 2012 13:34:01 -0800 Methods for selective extraction and fractionation of algal proteins from an algal biomass or algal culture are disclosed. A method of selective removal of products from an algal biomass provides for single and multistep extraction processes which allow for efficient separation of algal proteins. These proteins can be used as... http://www.freshpatents.com/-dt20120202ptan20120029171.php Mon, 6 Feb 2012 13:34:01 -0800 The present invention relates to a method for producing high affinity antibodies that are antigen-specific. The method involves binding a plurality of antibody-producing B-cells from a mammal to a plurality of cognate antigens; sorting the bound antibody-producing B-cell and cognate antigen; amplifying nucleic acid sequences encoding each antibody, or fragment... http://www.freshpatents.com/-dt20120202ptan20120029172.php Mon, 6 Feb 2012 13:34:01 -0800 Chimeric antibodies, as well as fusion proteins which comprise chimeric antibodies, are disclosed. The antibodies bind to GM-CSF, CD-30, and G250 antigen. The fusion proteins include biologically active portions of tumor necrosis factor, or full length tumor necrosis factor. Expression vectors adapted for production of the antibodies, as well as... http://www.freshpatents.com/-dt20120202ptan20120029173.php Mon, 6 Feb 2012 13:34:01 -0800 The present invention is drawn to a live, attenuated S. Paratyphi A strain, a live, attenuated S. Paratyphi A strain comprising a stabilized plasmid expression system, an S. Paratyphi conjugate vaccine, and methods of using these strains and conjugate vaccine.... http://www.freshpatents.com/-dt20120202ptan20120029174.php Mon, 6 Feb 2012 13:34:01 -0800 The present invention provides methods for effectively and efficiently converting methylotrophic yeast's heterogeneous high mannose-type N-glycosylation to mammalian-type N-glycosylation by disruption of an endogenous glycosyltransferase gene (OCH1) and step-wise introduction of heterologous glycosidase and glycosyltransferase activities. Each engineering step includes a number of stages: transformation with an appropriate vector, cultivation... http://www.freshpatents.com/-dt20120202ptan20120029175.php Mon, 6 Feb 2012 13:34:01 -0800 A process for producing an embedded protein antigen, comprising embedding a protein antigen having two or more cysteine residues in a molecule thereof, into a hydrophobized polysaccharid. Prior to or after the embedding of the protein antigen, the protein antigen is purified. There are provided an embedded protein antigen and... http://www.freshpatents.com/-dt20120202ptan20120029176.php Mon, 6 Feb 2012 13:34:01 -0800 Adsorptive media for chromatography, particularly ion-exchange chromatography, derived from a shaped fiber. In certain embodiments, the functionalized shaped fiber presents a fibrillated or ridged structure which greatly increases the surface area of the fibers when compared to ordinary fibers. Also disclosed herein is a method to add surface pendant functional...